- Home
- BALY vs ENGN Comparison
BALY vs ENGN Comparison
Compare BALY & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BALY | ENGN |
|---|---|---|
| Founded | 2004 | 1999 |
| Country | United States | Canada |
| Employees | 10000 | 82 |
| Industry | Hotels/Resorts | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 683.8M | 647.1M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | BALY | ENGN |
|---|---|---|
| Price | $12.59 | $7.27 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 5 |
| Target Price | $15.40 | ★ $21.00 |
| AVG Volume (30 Days) | 87.4K | ★ 431.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,450,478,000.00 | N/A |
| Revenue This Year | $6.47 | N/A |
| Revenue Next Year | $6.48 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 0.06 | N/A |
| 52 Week Low | $8.46 | $2.66 |
| 52 Week High | $20.74 | $12.25 |
Technical Indicators
Market Signals| Indicator | BALY | ENGN |
|---|---|---|
| Relative Strength Index (RSI) | 38.04 | 32.11 |
| Support Level | $11.83 | $6.03 |
| Resistance Level | $14.88 | $7.33 |
| Average True Range (ATR) | 0.98 | 0.63 |
| MACD | -0.05 | -0.33 |
| Stochastic Oscillator | 12.50 | 10.70 |
Price Performance
Historical ComparisonAbout BALY Bally's Corporation
Ballys Corp is a gaming, hospitality, and entertainment company with a portfolio of casinos and resorts and a growing omnichannel presence. It provides customers with physical and interactive entertainment and gaming experiences, including traditional casino offerings, iGaming, online bingo, sportsbook, and free-to-play (F2P) games. The company owns and operates, several casinos across the United States, one golf course in New York, one horse racetrack in Colorado, and Aspers Casino in the United Kingdom. Its Interactive International division, an interactive gaming operator concentrated in Europe, operates a lottery management and services business. The company's reportable segments are Casinos and Resorts, which derive key revenue, International Interactive and North America Interactive.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company mainstreaming genetic medicine through the delivery of therapeutics to mucosal tissues and other organs, with the goal of creating new ways to address diseases with high clinical needs, beginning with non-muscle invasive bladder cancer (NMIBC). The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.